12-Week Dosing Schedule for Ipilimumab/Nivolumab May Reduce Grade 3-5 TRAEs in Advanced RCC

1 year ago 32

A modified dosing schedule may make treatment with ipilimumab plus nivolumab more tolerable for patients with advanced renal cell carcinoma.

1. Homepage
2. category-label-
3. 12-Week Dosing Schedule for Ipilimumab/Nivolumab May Reduce Grade 3-5 TRAEs in Advanced RCC